Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergies
IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729
April 3rd, 2009
IBT Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, will launch a new diagnostic assay designed to help physicians better understand and manage their patients who have recurrent infections. The company will introduce the Pneumococcal Antibody Avidity Test at the annual meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), which opens tomorrow in Washington, DC. The exhibition runs Saturday, March 14 through Monday, March 16, 2009. According to IBT President, Maureen Loftus, the test builds on the company's suite of assays evaluating immune function. "IBT Laboratories was...
Source: Health Business Week (2009-04-03)
|
